Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 4/20 | 0.36 |
| ▸ | GABRP | O00591 | 4/20 | 0.35 |
| ▸ | GABRD | O14764 | 4/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.35 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.35 |
| ▸ | GABRE | P78334 | 4/20 | 0.35 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.35 |
| ▸ | GABRG1 | Q8N1C3 | 4/20 | 0.35 |
| ▸ | GABRG3 | Q99928 | 4/20 | 0.35 |
| ▸ | GABRQ | Q9UN88 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3176034 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL6177030 | 0.94 | — | — | |
| Ethylamine SCHEMBL28030590 | 0.87 | CYP2D6 (0.37) | SLC7A5CYP2D6CYP2C19DPP4GABRP | |
| Toluene SCHEMBL11338286 | 0.79 | LMNA (0.49) | TP53ALDH1A1LMNAMAPT | |
| Isopropylamine SCHEMBL910714 | 0.77 | ALDH1A1 (0.42) | SLC7A5CYP2D6CYP2C19DPP4GABRP | |
| SCHEMBL15664260 | 0.74 | — | — | |
| SCHEMBL21995235 | 0.74 | — | — | |
| SCHEMBL21995234 | 0.74 | — | — | |
| SCHEMBL15664303 | 0.74 | — | — | |
| SCHEMBL1938866 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1846422-B1 | ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS | INKTEC CO LTD (KR) | 2016-04-13 | — | — | EP | claimed |
| CN-101107257-B | Organic silver complex, method for producing same, and method for forming thin layer using same | INKTEC CO LTD | 2012-11-07 | — | — | CN | claimed |
| EP-2995620-B1 | ORGANIC SILVER COMPLEX, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYRERS | INKTEC CO LTD (KR) | 2018-09-19 | — | — | EP | disclosed |
| US-9914743-B2 | Organic silver complexes, their preparation methods and their methods for forming thin layers | INKTEC CO., LTD. (KR) | 2018-03-13 | — | — | US | disclosed |
| US-20160194339-A1 | Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers | INKTEC CO., LTD. (KR) | 2016-07-07 | — | — | US | disclosed |
| EP-1846422-B1 | ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS | INKTEC CO LTD (KR) | 2016-04-13 | — | — | EP | disclosed |
| EP-2995620-A1 | ORGANIC SILVER COMPLEX, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYRERS | Inktec Co., Ltd. (KR) | 2016-03-16 | — | — | EP | disclosed |
| US-20140179944-A1 | Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers | INKTEC CO., LTD. (KR) | 2014-06-26 | — | — | US | disclosed |
| US-8679242-B2 | Organic silver complexes, their preparation methods and their methods for forming thin layers | INKTEC CO., LTD. (KR) | 2014-03-25 | — | — | US | disclosed |
| US-20130022761-A1 | Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers | INKTEC CO., LTD. (KR) | 2013-01-24 | — | — | US | disclosed |
| CN-101107257-B | Organic silver complex, method for producing same, and method for forming thin layer using same | INKTEC CO LTD | 2012-11-07 | — | — | CN | disclosed |
| CN-102702237-A | Organic silver complex, method for producing same, and method for forming thin layer using same | INKTEC CO LTD | 2012-10-03 | — | — | CN | disclosed |
| US-8226755-B2 | Organic silver complexes, their preparation methods and their methods for forming thin layers | INKTEC CO., LTD. (KR) | 2012-07-24 | — | — | US | disclosed |
| US-20090120800-A1 | Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers | INKTEC CO., LTD. (KR) | 2009-05-14 | — | — | US | disclosed |
| CN-101107257-A | Organic silver complex, method for producing same, and method for forming thin layer using same | INKTEC CO LTD (KR) | 2008-01-16 | — | — | CN | disclosed |
| EP-1846422-A1 | ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS | Inktec Co., Ltd. (KR) | 2007-10-24 | — | — | EP | disclosed |
| WO-2006083153-A1 | ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS | INKTEC CO., LTD. (KR) | 2006-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090120800-A1 | Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers | CA3, C9, CLTC | SLC7A5 461/4885CYP2D6 3021/4885CYP2C19 1955/4885 |
| US-20140179944-A1 | Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers | C9, CA3, C5 | SLC7A5 858/4885CYP2D6 3155/4885CYP2C19 2406/4885 |
| US-20160194339-A1 | Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers | AGPS, DNMT1, TUBA3C | SLC7A5 1386/4885CYP2D6 3343/4885CYP2C19 2349/4885 |
| US-20130022761-A1 | Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers | CA3, C9, CLTC | SLC7A5 461/4885CYP2D6 3021/4885CYP2C19 1955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.